Against the backdrop of accelerated global biopharmaceutical industry evolution and continuously upgrading domestic health consumption demands, the biopharmaceutical and nutritional health sectors are witnessing unprecedented development opportunities. Jining Hengkang Biopharmaceutical Co., Ltd. (hereinafter referred to as “Jining Hengkang”), headquartered in Jiaxiang, Jining—the birthplace of Confucius and Mencius—specializes in the research, development, and production of health foods, general foods, and cosmetics. Guided by technological innovation, grounded in rigorous quality control, and committed to compliant operations, the company has steadily advanced amid industry transformations, contributing to the high-quality development of the regional health industry.
I. Strengthening the Foundation: Deepening the Health Industry and Building a Comprehensive Development System
Since its establishment, Jining Hengkang has consistently focused on the core segments of the broader health industry. It is a comprehensive high-tech enterprise integrating scientific research and development, production, marketing, and technical services. Located in Dazhanglou Town, Jiaxiang County, the company occupies a factory area of 7,000 square meters and has invested over 60 million yuan in constructing a modern production base. The facility is equipped with standardized clean workshops, automated production lines, and specialized testing laboratories, enabling the R&D and large-scale production of various product categories, including health foods, special dietary foods, gel candies, solid beverages, and cosmetics.
With its comprehensive industrial layout and robust production capabilities, Jining Hengkang has gradually established a full-chain operational system encompassing “raw material control—R&D innovation—production management—quality testing—market services.” From strictly adhering to national standards during raw material selection, to implementing refined management practices in production, and conducting comprehensive testing before product release, the company consistently prioritizes product safety and quality. It delivers safe, high-quality, and efficient health products to consumers while also driving the standardized development of the industry.
II. Innovation Empowerment: Focusing on Technological Breakthroughs to Activate the Core of Corporate Development
Innovation constitutes the core competitiveness of biopharmaceutical enterprises and serves as the key driving force for Jining Hengkang’s sustainable development. The company places high priority on R&D investment, having established a specialized R&D team focused on three major areas: nutritional health, functional foods, and natural skincare. It delves into formula optimization, process upgrades, and new product development, continuously launching innovative products that meet market demands.
Leveraging its strengths as a high-tech enterprise, Jining Hengkang actively engages with cutting-edge industry technologies and explores the integrated application of biotechnology and the health industry, accumulating technical expertise in specialized fields such as specialized dietary nutrition, plant extracts, and gel candies. Meanwhile, the company utilizes local enterprise-friendly policies, including tax incentives such as the additional VAT deduction for advanced manufacturing, converting these policy benefits into R&D investments. This approach further alleviates funding pressures for new product development and accelerates the commercialization of technological achievements.
In terms of product innovation, the company has developed a diversified product portfolio focused on specific healthcare scenarios such as maternal and infant nutrition, health for middle-aged and elderly individuals, daily wellness, and skin care. Ranging from specialized maternal and infant dietary products like Tebeiyuan Pregnancy Nourishment Formula, to functional foods such as sea buckthorn seed oil gel candies and peony seed oil gel candies, as well as plant-based essential oil skincare products, Jining Hengkang continuously enriches its product portfolio based on precise market demands to meet the health needs of diverse consumer groups.
III. Compliance First: Upholding Quality Standards and Embracing Industry Responsibilities
The biopharmaceutical and health industry is vital to public well-being, where compliant operations and rigorous quality control form the foundation for corporate sustainability. Jining Hengkang consistently adheres to the business philosophy of “Quality First, Compliance Foremost,” strictly complying with the Food Safety Law and the Good Manufacturing Practice (GMP) regulations for health foods. The company has established a comprehensive quality control system covering the entire process—from raw material procurement and production to finished product release.
In production management, the company implements standardized operational procedures, conducting comprehensive monitoring of the entire process—including the production environment, equipment maintenance, personnel operations, and material flow—to ensure compliance and controllability of the production process. For quality control, specialized testing equipment is employed to rigorously analyze product parameters such as nutritional composition, microbial indicators, and heavy metal content, thereby preventing substandard products from entering the market.
In response to the new landscape of increasingly stringent industry regulations, Jining Hengkang proactively aligns with regulatory requirements and actively cooperates with market supervision authorities in sampling inspections. The company conducts regular self-inspections and corrections focusing on critical aspects such as product nutritional composition and labeling, continuously optimizing product formulations and manufacturing processes. With a rigorous approach and stringent standards, Hengkang fulfills its corporate responsibilities and upholds an integrity-driven business environment within the industry.
IV. Moving Forward with Unity: Seizing Industry Opportunities to Build a Shared Future for the Health Industry.
Currently, China’s biomedical and health industry is in a golden period of development, supported by policy incentives, expanding demand, and technological innovation. The continuous advancement of the “Healthy China 2030” Planning Outline and the growing public awareness of health consumption have created vast opportunities for industry growth. Meanwhile, AI-driven R&D, breakthroughs in biotechnology, and the refinement of regulatory frameworks are driving the industry toward higher quality, greater standardization, and enhanced innovation.
As a local biomedical enterprise in Jining, Jining Hengkang will seize industry development opportunities, leverage regional industrial advantages, continuously increase R&D investment, enhance technological innovation capabilities, optimize product portfolios, and strengthen product core competitiveness. Simultaneously, the company will deepen compliance management, strictly adhere to quality standards, actively fulfill social responsibilities, and establish a positive corporate image.
In the future, Jining Hengkang will continue to adhere to its development philosophy of “focusing on health, technological innovation, and quality as the foundation,” deepen its expertise in the biopharmaceutical and healthcare industries, persistently pursue innovation, enhance the company’s overall competitiveness, and strive to become a leading benchmark enterprise in the regional healthcare sector. Hengkang is committed to contributing its strength to promoting the high-quality development of the biopharmaceutical industry in Jining and nationwide, while safeguarding public health.